PAPER Zhang Y, Xu Z, Shen X, Pan W, Alzheimer's Disease Neuroimaging Initiative
SEARCH RESULTS
331171 RESULTS
PAPER Oehlrich D, Prokopcova H, Gijsen HJ
The evolution of amidine-based brain penetrant BACE1 inhibitors.
Bioorg Med Chem Lett. 2014 May 1;24(9):2033-45. Epub 2014 Mar 20 PubMed: 24704031PAPER Díaz A, Rojas K, Espinosa B, Chávez R, Zenteno E, Limón D, Guevara J
Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats.
Neuropeptides. 2014 Jun;48(3):153-9. Epub 2014 Mar 24 PubMed: 24703968PAPER Simonson W
Vitamin E for Alzheimer's disease?
Geriatr Nurs. 2014 Mar-Apr;35(2):147-8. PubMed: 24703434PAPER Liu Y, Yu JT, Zhang W, Zong Y, Lu RC, Zhou J, Tan L
Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese.
J Neuroimmunol. 2014 Jun 15;271(1-2):43-8. Epub 2014 Mar 21 PubMed: 24703098PAPER Rokka J, Snellman A, Zona C, La Ferla B, Nicotra F, Salmona M, Forloni G, Haaparanta-Solin M, Rinne JO, Solin O
Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Bioorg Med Chem. 2014 May 1;22(9):2753-62. Epub 2014 Mar 18 PubMed: 24702859PAPER Bolognin S, Buffelli M, Puoliväli J, Iqbal K
Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.
Neurobiol Aging. 2014 Sep;35(9):2134-46. Epub 2014 Mar 2 PubMed: 24702821PAPER Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Neurobiol Aging. 2014 Sep;35(9):2096-106. Epub 2014 Mar 11 PubMed: 24702820PAPER Xiong J, Roach CA, Oshokoya OO, Schroell RP, Yakubu RA, Eagleburger MK, Cooley JW, Jiji RD
Role of bilayer characteristics on the structural fate of aβ(1-40) and aβ(25-40).
Biochemistry. 2014 May 13;53(18):3004-11. Epub 2014 Apr 23 PubMed: 24702518PAPER Berk C, Paul G, Sabbagh M
Investigational drugs in Alzheimer's disease: current progress.
Expert Opin Investig Drugs. 2014 Jun;23(6):837-46. Epub 2014 Apr 5 PubMed: 24702504PAPER Wang CY, Wang ZY, Xie JW, Cai JH, Wang T, Xu Y, Wang X, An L
CD36 Upregulation Mediated by Intranasal LV-NRF2 Treatment Mitigates Hypoxia-Induced Progression of Alzheimer's-Like Pathogenesis.
Antioxid Redox Signal. 2014 May 16; PubMed: 24702189PAPER He XP, Deng Q, Cai L, Wang CZ, Zang Y, Li J, Chen GR, Tian H
Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease.
ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5379-82. Epub 2014 Apr 8 PubMed: 24702005PAPER Ten Brinke LF, Bolandzadeh N, Nagamatsu LS, Hsu CL, Davis JC, Miran-Khan K, Liu-Ambrose T
Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial.
Br J Sports Med. 2014 Apr 7; PubMed: 24711660PAPER Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL
Evaluation of mild cognitive impairment subtypes in Parkinson's disease.
Mov Disord. 2014 May;29(6):756-64. Epub 2014 Apr 7 PubMed: 24710804PAPER Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, Song DD, Liu L, Filoteo JV
The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment.
Parkinsonism Relat Disord. 2014 Jun;20(6):627-31. Epub 2014 Mar 20 PubMed: 24709086Current Filters
No filters selected